Mindbloom 101

6 session program

Learn how to leverage the science and neurological benefits of ketamine therapy to maximize your healing potential and set yourself up for long-term success.*

Am I a candidate?

Program details

Led by integration expert Dr. Katherine Coder, Mindbloom 101 introduces you to the transformative potential of psychedelic therapy. This comprehensive program emphasizes the importance of preparation and integration, guiding you through every step of the process. By carefully preparing for your psychedelic experience and thoughtfully integrating the insights gained, you can leverage this powerful modality to achieve profound personal growth, emotional healing, and a greater sense of well-being. *A diagnosis of anxiety, depression, or PTSD is required for Mindbloom treatment. Eligibility will be determined by a Mindbloom clinician during your initial consultation.

What does ketamine feel like?

Ketamine therapy often feels like a weightless, dreamlike state. The medicine produces a gentle, introspective, and positive experience where you can gain new insights on the roots of your anxiety and/or depression. Each session typically lasts 45 minutes-1 hour, and you can resume your daily activities shortly thereafter.

Your sessions take place at home, providing comfort and ease that enable you to heal.

What’s included with treatment?

As part of your treatment plan, you will receive:

2 Clinician consults to manage your progress and prescription.
3 Guide coaching sessions to help you prepare for, unpack, and integrate your experiences.
Unlimited messaging with your guide
Unlimited Group Integration Circles to connect and heal with others
Ongoing dosage support to ensure meaningful experiences
A Bloombox which contains everything you need for safe, effective, and powerful sessions
10+ Comprehensive programs with custom soundscapes, and detailed preparation and integration resources.
Access to the Mindbloom App to seamlessly guide you through each step of the process

more programs

Mindbloom for Anxiety

Explore

Mindbloom for Depression

Explore

Safety information

Important Safety Information

Mindbloom pairs individuals with licensed clinicians who are trained to diagnose and treat anxiety, depression, and other mental health conditions. If one of the licensed clinicians, in their medical judgment, decides that ketamine is an appropriate treatment for an individual based on a clinical assessment, then the clinician may prescribe ketamine tablets that are compounded by pharmacies under Section 503A of the federal Food, Drug, and Cosmetic Act (FDCA). Drugs compounded under Section 503A do not require FDA approval, and as such the FDA has not determined that the compounded ketamine prescribed is safe and effective for anxiety, depression, or other mental health conditions. The use of ketamine for anxiety, depression, and many other mental health conditions, however, is supported by a body of scientific literature. (Data on file).

Ketamine is a Schedule III controlled substance. Other drugs containing ketamine, which (unlike compounded drugs) are subject to FDA’s approval requirements, have been FDA-approved as an intravenous or intramuscular injection solution for induction and maintenance of general anesthesia. However, those drugs have not been FDA-approved for anxiety, depression, or other mental health conditions, and they have not been FDA-approved in tablet form. The approved label is available here.

Ketamine may cause serious side effects, including but not limited to risks of: sedation; dissociation; psychiatric events or worsening of psychiatric disorders, including problems in people with schizophrenia, severe personality disorders, or other serious mental disorders; dependence, abuse and misuse; anxiety; increases in blood pressure or heart rate; respiratory depression (breathing becomes slower and shallower and the lungs fail to exchange carbon dioxide and oxygen efficiently); lower urinary tract and bladder symptoms, including frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size; altered sense of time; dry mouth; elevated intraocular or intracranial pressure; loss of appetite; confusion; nausea/vomiting; blurred vision; and slurred speech.

The FDA has advised that at-home administration of compounded ketamine may present additional risks because a health care provider is not available onsite to monitor for adverse outcomes resulting from sedation and dissociation.

Mindbloom’s protocols and guidance have been designed to minimize the likelihood of experiencing these side effects or other adverse effects, and should be followed carefully. Ketamine should only be taken as directed by the treating clinician.

Do not proceed with ketamine treatment if any of the following apply to you:

Allergic to ketamine
Symptoms of psychosis or mania
Uncontrolled high blood pressure
CHF or other serious heart problem
Severe breathing problem
History of elevated intraocular or intracranial pressure
History of hyperthyroidism
Other serious medical illness
Pregnant, nursing, or trying to become pregnant

Ketamine has been found to cause moderate psychological dependency in some users.

In rare cases, frequent, heavy users have reported increased frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size
Ketamine may worsen problems in people with schizophrenia, severe personality disorders, or other serious mental disorders
Users with a personal or family history of psychosis should be cautious using any psychoactive substance, including ketamine, and discuss potential risks with your clinician before proceeding with treatment
The dissociative effects of ketamine may increase patient vulnerability and the risk of accidents

To promote positive outcomes and ensure safety, follow these ketamine treatment guidelines:

Do not operate a vehicle (e.g., car, motorcycle, bicycle) or heavy machinery following treatment until you’ve had a full night of sleep
Refrain from taking benzodiazepines or stimulants for 24 hours prior to treatment
Continue to take antihypertensive medication as prescribed
Do not take ketamine while hungover or with alcoholic beverages
Refrain from consuming solid foods within 3 hours prior to treatment and liquids within 1 hour prior to treatment
Ketamine treatment should never be conducted without a peer treatment monitor physically present

A peer-reviewed study of Mindbloom’s client treatment outcomes was published in the Journal of Affective Disorders in 2022, titled At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial. The FDA has not evaluated head-to-head trials comparing the safety of ketamine to other medications that are FDA-approved for the treatment of depression, anxiety, or other psychiatric disorders. Although some clients report that they had more success with ketamine than with FDA-approved therapies, these outcomes may not be typical.

For more information about the informed consent that clients review and sign prior to treatment, please visit mindbloom.com/informed-consent.

A TRANSFORMATIVE program that gets to the ROOT of your challenges

By addressing both the acute symptoms and the long-term cognitive patterns associated with anxiety, ketamine therapy offers a comprehensive approach to healing.

Go deep into the science of ketamine therapy and how this creates fertile ground for new ways of thinking, acting, and being.

Gain a comprehensive understanding of psychedelic healing and learn how to achieve the best possible results.

Experience immediate relief from anxious and depressive symptoms and create an action plan for long-term healing.

the ketamine difference

Neuroplasticity means your brain can change.

Our science-backed program combined with the transformative potential of ketamine can help you break free from the rigid patterns of worry and fear that characterize anxiety, fostering more adaptive and resilient thought processes.

Real client reviews with real results. We hear every day how this treatment changes lives.

I thought I was broken. Now, the light inside me is growing stronger every day.

I wasn’t getting anywhere with traditional therapy and antidepressants. Mindbloom allowed me to look at the root of my anxiety, depression, and PTSD. I could finally see a path to healing.

— Alan B.

Ketamine therapy has changed my life – perhaps even saved it.

I suffered from crippling anxiety, depression, and had become treatment-resistant. I tried Mindbloom out of literal desperation. It has improved my job performance, my relationships, and my ability to cope with everyday challenges.

— Leslie L.

I’m hopeful and excited for what’s to come.

I've suffered with depression and anxiety for decades. I felt numb on traditional antidepressants, and at best, was just limping through life. My journey with Mindbloom is helping me to recapture my life.

— Ray C.

I refer to my journey with ketamine as my "reawakening."

After my 1st Mindbloom session, my brain fog, depression, and anxiety began to lift. It's allowed me to slowly regain my ability to live life rather than scrape by in survival mode. It’s the only thing in over twenty years that has helped me. My only regret is not doing this sooner.

— Dana W.

I’ve built a foundation to keep me from spiraling and feeling lost.

After trying several SSRIs in the past with little to no positive results, I thought that there wasn’t much out there for me. I didn’t want to take medication for the rest of my life that would act like a bandaid for the deeper anxiety/depression issues that I had. Mindbloom provided the support I needed to make sure my progress was moving in the right direction. Progress that would stick.

— Andrew Y.

I have hope and my outlook on life is completely different

Mindbloom was so transformative for me that I think of my life as two distinct periods of time: Before and after ketamine therapy. I’m now able to give myself the compassion that I need to grow, learn, and thrive.

— Dan B.